Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Franzese

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 30, 2017
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective studyT Comito, L Cozzi, A Zerbi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 29, 2023
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient SurvivalC Franzese, R Lucchini, M Roghi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 15, 2023
Stereotactic Body Radiotherapy for Spine Oligometastases: A Multicentre Retrospective Study From the Italian Association of Radiotherapy and Clinical Oncology (AIRO)F Cuccia, E Pastorello, C Franzese, et al.
Journal of Chemotherapy (Florence, Italy)|July 12, 2011
Pegylated liposomal doxorubicin (Caelyx®) and oral vinorelbine in first-line metastatic breast cancer patients previously treated with anthracyclinesL Livi, I Meattini, V Scotti, et al.
Technology in Cancer Research & Treatment|June 18, 2016
Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a Phase 2 StudyTiziana Comito, L Cozzi, E Clerici, et al.
Clinical Genitourinary Cancer|September 13, 2025
Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter StudyF Mastroleo, R Villa, M Zaffaroni, et al.
European Journal of Hybrid Imaging|June 30, 2021
Does a 6-point scale approach to post-treatment 18F-FDG PET-CT allow to improve response assessment in head and neck squamous cell carcinoma? A multicenter studyP Bonomo, A Merlotti, S Morbelli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 2024
Oligometastatic sarcoma treated with Curative intent Ablative Radiotherapy (OSCAR): A multicenter study on behalf of AIRO (Italian association of Radiotherapy and clinical Oncology)D Franceschini, D Greto, S Dicuonzo, et al.
Rhinology|October 10, 2024
Nasal endoscopy score thresholds to trigger consideration of chronic rhinosinusitis treatment escalation and implications for disease controlA R Sedaghat, R A Cotter, I Alobid, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 30, 2017
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective studyT Comito, L Cozzi, A Zerbi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 29, 2023
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient SurvivalC Franzese, R Lucchini, M Roghi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 15, 2023
Stereotactic Body Radiotherapy for Spine Oligometastases: A Multicentre Retrospective Study From the Italian Association of Radiotherapy and Clinical Oncology (AIRO)F Cuccia, E Pastorello, C Franzese, et al.
Journal of Chemotherapy (Florence, Italy)|July 12, 2011
Pegylated liposomal doxorubicin (Caelyx®) and oral vinorelbine in first-line metastatic breast cancer patients previously treated with anthracyclinesL Livi, I Meattini, V Scotti, et al.
Technology in Cancer Research & Treatment|June 18, 2016
Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a Phase 2 StudyTiziana Comito, L Cozzi, E Clerici, et al.
Clinical Genitourinary Cancer|September 13, 2025
Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter StudyF Mastroleo, R Villa, M Zaffaroni, et al.
European Journal of Hybrid Imaging|June 30, 2021
Does a 6-point scale approach to post-treatment 18F-FDG PET-CT allow to improve response assessment in head and neck squamous cell carcinoma? A multicenter studyP Bonomo, A Merlotti, S Morbelli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 2024
Oligometastatic sarcoma treated with Curative intent Ablative Radiotherapy (OSCAR): A multicenter study on behalf of AIRO (Italian association of Radiotherapy and clinical Oncology)D Franceschini, D Greto, S Dicuonzo, et al.
Rhinology|October 10, 2024
Nasal endoscopy score thresholds to trigger consideration of chronic rhinosinusitis treatment escalation and implications for disease controlA R Sedaghat, R A Cotter, I Alobid, et al.
Pageof 4